Physician profile
Alexa Herzig
NPI 1164077004
$14,240.71
in general payments reported to CMS, 2019-2025
31 companies · $3,540 in 2025
The $3,540 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $574 · 2022: $2,878 · 2023: $3,164 · 2024: $4,084 · 2025: $3,540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,688.76 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $2,763.58 | 2021-2025 | |
| Abbvie INC. | $2,743.43 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,372.05 | 2021-2025 | Dupixent |
| Dermavant Sciences, INC. | $771.92 | 2022-2024 | Vtama |
| E.R. Squibb & Sons, L.L.C. | $730.52 | 2022-2025 | Sotyktu |
| Incyte Corporation | $726.07 | 2022-2025 | Opzelura |
| Galderma Laboratories, L.P. | $633.64 | 2021-2025 | Nemluvio, Oracea, Aklief |
| Novartis Pharmaceuticals Corporation | $556.77 | 2022-2025 | |
| Leo Pharma INC. | $523.76 | 2022-2025 | Adbry, Anzupgo |
| Arcutis Biotherapeutics, INC. | $429.13 | 2023-2025 | Zoryve |
| Ucb, INC. | $400.82 | 2024-2025 | Bimzelx |
| Allergan, INC. | $383.61 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $371.88 | 2022-2025 | |
| Revance Therapeutics, INC. | $349.05 | 2024-2025 | Daxxify |
| Lilly USA, LLC | $255.87 | 2022-2025 | Taltz, Ebglyss, Olumiant |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $232.57 | 2022-2025 | Xepi, Bf-Rhodoled, Ameluz |
| Botanix Sb INC | $169.07 | 2025 | Sofdra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $162.98 | 2024-2025 | Duobrii, Siliq, Arazlo |
| Amgen INC. | $125.78 | 2023-2025 | Otezla, Otezla |
| Janssen Biotech, INC. | $111.13 | 2022-2023 | Tremfya, Simponi Aria, Simponi |
| Almirall LLC | $73.28 | 2022 | |
| Pfizer INC. | $72.75 | 2023-2025 | |
| Merz North America, INC. | $70.27 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $60.00 | 2022 | |
| Mayne Pharma Commercial LLC | $45.28 | 2022-2023 | |
| Journey Medical Corporation | $28.71 | 2022 | |
| Verrica Pharmaceuticals INC. | $20.07 | 2024 | Ycanth |
| Kyowa Kirin, INC. | $17.37 | 2025 | |
| Epi Health, LLC | $16.99 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.16 | 2023 | Spevigo |
| Organon LLC | $8.20 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexa Herzig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.